drug · small molecule
nalbuphine hydrochloride ER
Phase 3updated 3mo agoby $TRVI Trevi Therapeutics, Inc.🔗 ChEMBL
Phase 3community read0 votes
🐶 often sniffed alongside
top 2Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for pain and 7 investigational indications.
targets
Opioid receptors; mu/kappa/delta
all catalysts(0)
nothing on the calendar yet
Trials studying nalbuphine hydrochloride ER
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 11m ago
Found something off?
comments(0)
5-min edit window · permanent after that